Clinical Characteristics and Outcomes of Patients With Mpox Who Received Tecovirimat in a New York City Health System.
Journal Information
Full Title: Open Forum Infect Dis
Abbreviation: Open Forum Infect Dis
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Potential conflicts of interest. All authors had access to prescribe tecovirimat based on the CDC EA-IND protocol and local IRB approval. L. L. and G. P. are co-investigators on STOMP, and J. A. is the site principal investigator for the STOMP trial at the Icahn School of Medicine at Mount Sinai. All other authors report no potential conflicts."
Funding Disclosure
Evidence found in paper:
"Financial support. No funding was available or used for this study. Financial support."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025